April 25, 2022 – HealthEdge Investment Partners, LLC (“HealthEdge”), a healthcare focused private equity fund, announced today that it has completed an investment in Anodyne, LLC (“Anodyne”), a leading provider of lifestyle-oriented clinical footwear solutions most commonly prescribed for diabetic patients. Anodyne was founded in 2015 by a group of industry executives who set out to reimagine the diabetic footwear market and establish a new, leading brand—one that would offer patients a variety of modern and stylish shoe selections and suppliers an unmatched service experience. Over the …
News & Updates
Convergence Healthcare Advisors serves as strategic adviser to Humanscale in the sale of Humanscale Healthcare to Capsa Healthcare
Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Humanscale Healthcare, a designer and manufacturer of flexible technology solutions and computing workstations based in New York, NY. Capsa’s purchase of Humanscale Healthcare is the company’s seventh major brand acquisition in the last 11 years. With 50+ years of product innovation experience, Capsa has grown steadily through a combination of internal development and acquisition of complementary product brands and technology …
Convergence Healthcare Advises Horizon Discovery in the divestiture of its Animal Research Models business to Envigo
Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation technologies, today announces an agreement to divest the Group’s animal research models business unit (“the business unit”) to Envigo RMS LLC (“Envigo”). The divestment forms part of Horizon’s strategy to refocus on high growth areas within its ore market and is expected to be completed within 30-45 days, subject to customary closing conditions. Already a well-established supplier of gene editing and gene modulation reagents, libraries and …
Convergence Healthcare Advisors served as exclusive strategic advisor to Natera, Inc. on the sale of the Evercord business to CBR.
LOS ANGELES, Sept. 13, 2019 /PRNewswire/ — CBR (Cord Blood Registry), the world’s largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc.’s (NASDAQ: NTRA) Evercord™ newborn stem cell business. The mutually beneficial move brings together two of the industry’s most respected newborn stem cell storage companies. “As a pillar of the California Cryobank Life Sciences (CCLS) organization, CBR is built on scientific excellence, leadership, and best-in-class services,” said Richard Jennings, California Cryobank Life Sciences, CEO. …
Seven Hills Healthcare Advisors represents HEALTHGRID in sale to ALLSCRIPTS HEALTHCARE SOLUTIONS
Seven Hills Healthcare Advisors represents HEALTHGRID in sale to ALLSCRIPTS HEALTHCARE SOLUTIONS May 3, 2018 Seven Hills Healthcare Advisors* is pleased to announce our role as exclusive strategic advisor to Health Grid Holding Company in its sale to Allscripts Healthcare Solutions. Terms of the transaction were not disclosed. HealthGrid is a leader in the rapidly evolving healthcare patient engagement sector. Industry analyst KLAS defines patient engagement as “the process of motivating and enabling patients to participate in their own care with the expectation that, over time, …
Convergence Healthcare advises Dynex Technologies in its sale to Telegraph Hill Partners
Dynex Technologies (Dynex) has been acquired by Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated to the life science and healthcare industries. THP will infuse Dynex with significant resources and capital, enabling the company to expand its operations, improve manufacturing capacity and grow its client services organization. “We are proud of our 60-year history of delivering best in class products with an ongoing commitment to innovation. With THP’s additional resources, we look forward to continuing to execute on our strategy for future growth,” …